ADENOSINE DEAMINASE, ADA-PERICARDIAL FLUID

Adenosine Deaminase (ADA) – Pericardial Fluid is a specialized biochemistry test that measures adenosine deaminase enzyme activity in fluid collected from the sac surrounding the heart. This fluid is known as pericardial fluid.

ADA is an enzyme involved in purine metabolism and is associated with lymphocyte activity during cellular immune responses. Increased ADA activity in pericardial fluid may support the evaluation of tuberculous pericarditis, a form of tuberculosis affecting the protective membrane around the heart.

Benefits of the Test

• Measures ADA enzyme activity in pericardial fluid.
• Supports evaluation of suspected tuberculous pericarditis.
• Provides additional information in patients with unexplained pericardial effusion.
• May help differentiate tuberculous inflammation from certain other causes.
• Supports clinical decisions while microbiological investigations are pending.
• Can be interpreted with pericardial-fluid cell count and biochemical findings.
• Helps identify patients requiring additional tuberculosis investigations.
• Provides quantitative laboratory-based assessment.
• Supports cardiology and infectious-disease evaluation.
• May contribute to timely investigation of a potentially serious condition.

Why Doctors Recommend This Test

Doctors may recommend this test when a patient has pericardial effusion or pericarditis with suspected tuberculosis. Possible symptoms include chest pain, breathlessness, persistent fever, fatigue, night sweats, unexplained weight loss, palpitations, cough, or swelling of the legs and abdomen.

Preparation Before Test

• The test requires pericardial fluid rather than a routine blood sample.
• Pericardial fluid is collected by a trained specialist, commonly through pericardiocentesis.
• No independent fasting is generally required for ADA analysis itself.
• Follow the hospital or cardiologist’s instructions regarding fasting before the fluid-collection procedure.
• Inform the doctor about anticoagulants, aspirin, antiplatelet medicines, and all other medications.
• Do not stop prescribed medicines unless specifically instructed by your doctor.
• Inform the doctor about bleeding disorders, allergies, pregnancy, previous heart procedures, and existing medical conditions.
• Blood tests, ECG, echocardiography, or other imaging may be performed before fluid collection.
• The fluid must be collected in an appropriate sterile, leak-proof container.
• The specimen must be correctly labelled, processed, stored, and transported according to laboratory requirements.

Normal Reporting Time

The ADA Pericardial Fluid test requires specialized biochemical analysis, result validation, and laboratory quality review. Results are generally available within 1–4 working days after receipt of a suitable specimen. The exact reporting time may vary according to the testing schedule, specimen transportation, storage conditions, repeat analysis, and laboratory workflow.

Who Should Take This Test?

This test may be recommended for:

• Patients with suspected tuberculous pericarditis.
• Individuals with unexplained pericardial effusion.
• Patients with persistent fever and fluid surrounding the heart.
• People with chest discomfort, breathlessness, and suspected pericarditis.
• Individuals with tuberculosis exposure and new cardiac symptoms.
• Patients with lymphocyte-predominant pericardial fluid.
• People with imaging findings suggestive of pericardial inflammation.
• Patients with inconclusive routine pericardial-fluid investigations.
• Immunocompromised individuals with suspected extrapulmonary tuberculosis.
• Patients specifically advised to undergo testing by a cardiologist or physician.

Detailed Information

The pericardium is a thin, double-layered sac surrounding the heart. A small amount of fluid normally lies between these layers and allows the heart to move smoothly. Accumulation of excessive fluid is called pericardial effusion.

Pericardial effusion may develop due to infections, inflammation, kidney disease, autoimmune disorders, cancer, injury, heart surgery, certain medicines, and other conditions. Laboratory analysis of pericardial fluid helps doctors investigate its cause.

Tuberculous pericarditis occurs when Mycobacterium tuberculosis infects or causes inflammation of the pericardium. It can lead to fluid accumulation, thickening of the pericardium, impaired heart filling, or constrictive pericarditis.

ADA converts adenosine into inosine as part of purine metabolism. Its activity is associated with lymphocytes, particularly T lymphocytes involved in the immune response against tuberculosis. Increased cellular immune activity may therefore raise ADA levels in affected pericardial fluid.

An elevated pericardial-fluid ADA result may increase clinical suspicion of tuberculous pericarditis when symptoms, imaging, fluid characteristics, exposure history, and local tuberculosis prevalence support the diagnosis.

An elevated ADA result does not independently confirm tuberculosis. Other infections, inflammatory conditions, lymphomas, and malignancies may also increase ADA activity. The result must therefore be correlated with microbiological and clinical findings.

A low or normal ADA result does not completely exclude tuberculous pericarditis. The disease stage, immune status, previous treatment, sample quality, and analytical method may influence the measured level.

Additional pericardial-fluid investigations may include cell count and differential count, protein, glucose, lactate dehydrogenase, Gram stain, bacterial culture, acid-fast bacillus smear, mycobacterial culture, TB molecular testing, and cytology.

Mycobacterial culture or molecular testing may provide more direct evidence of tuberculosis. Echocardiography, CT, MRI, blood tests, and pericardial biopsy may also be recommended depending on the clinical findings. Treatment should not be started or excluded solely on the basis of ADA.

Pericardial fluid is commonly collected through pericardiocentesis. During this procedure, a specialist uses imaging guidance to introduce a needle or catheter into the pericardial space. The procedure may be performed for diagnosis and to relieve pressure caused by excess fluid.

Pericardiocentesis must be performed in an appropriate clinical setting with monitoring and specialist supervision. The treating doctor determines whether the procedure is required and can be safely performed.

Blood contamination, turbidity, insufficient volume, incorrect container use, delayed processing, or improper storage may affect specimen suitability. Correct collection and transportation are essential for reliable results.

Severe breathlessness, fainting, confusion, low blood pressure, bluish skin, rapid worsening of chest pain, or extreme weakness may indicate pressure on the heart and require immediate emergency medical attention.

At Focus Diagnostics, ADA Pericardial Fluid testing is processed using established biochemical methodologies, appropriate specimen-handling procedures, analytical quality controls, and validation standards to provide clinically meaningful results.